13F Holdings
中文EN

SEER Seer, Inc.

Laboratory Analytical Instruments · Nasdaq · SEC CIK 1726445 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY-14.0%
TTM net income YoY20.0%
TTM EPS YoY—
Revenue 3-yr CAGR-5.8%
Net income 3-yr CAGR—

Margins

Gross margin46.5%
Operating margin-469.9%
Net margin-450.9%
FCF margin-329.3%
EBITDA margin-438.2%

Returns

ROE-26.2%
ROA-23.1%
ROIC (approx.)-25.5%
Asset turnover0.05x

Leverage & solvency

Liabilities / assets12.0%
Debt / equity0.00x
Current ratio16.89x
Interest coverage—

Cash quality & payout

Operating cash flow / net income0.71x
Accruals ratio-6.6%
Payout ratio—
Capex / revenue7.2%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31FY20232023-12-31FY20222022-12-31FY20212021-12-31
Income statement
Revenue$16.58M$14.17M$16.66M$15.49M$6.62M
Cost of revenue$8.11M$7.12M$8.15M$8.40M$3.21M
Gross profit$8.46M$7.05M$8.51M$7.09M$3.41M
R&D expense$43.87M$50.59M$53.02M$45.80M$29.12M
SG&A expense$42.58M$56.57M$58.95M$58.53M$45.76M
Operating income-$77.99M-$100.10M-$103.46M-$97.23M-$71.47M
Interest expense———$0$22,000
Pretax income-$73.40M-$86.50M-$86.28M——
Income tax$201,000$98,000$0$0$0
Net income-$73.60M-$86.60M-$86.28M-$92.97M-$71.17M
EBITDA-$72.87M-$94.27M-$98.11M-$93.33M-$68.87M
EPS (basic)——-1.35-1.49-1.17
EPS (diluted)——-1.35-1.49-1.17
Dividends declared per share0.000.000.00——
Weighted avg. shares (diluted)——63.85M62.43M60.86M
Balance sheet
Cash & equivalents$47.28M$41.28M$33.02M$53.73M$233.34M
Short-term investments$138.61M$195.66M$283.73M$368.03M$167.26M
Receivables——$4.83M$4.32M$2.50M
Inventory$7.79M$7.44M$4.49M$4.63M$4.14M
Current assets$201.53M$253.32M$330.51M$434.98M$411.70M
PP&E, net$14.75M$18.57M$22.19M$19.41M$13.09M
Total assets$296.08M$366.60M$436.27M$487.93M$539.14M
Current liabilities$15.69M$15.33M$13.22M$12.58M$13.42M
Total liabilities$36.78M$39.03M$39.37M$40.94M$36.22M
Shareholders' equity$259.31M$327.57M$396.90M$446.99M$502.92M
Shares outstanding———63.41M62.02M
Cash flow statement
Operating cash flow-$44.45M-$46.11M-$59.06M-$60.78M-$46.35M
Capital expenditure$1.80M$3.58M$7.31M$10.27M$6.92M
Free cash flow-$46.24M-$49.69M-$66.37M-$71.05M-$53.27M
Investing cash flow$61.55M$65.86M$37.90M-$122.72M-$170.88M
Financing cash flow-$10.57M-$11.49M$452,000$3.89M$116.63M
Depreciation & amortization$5.12M$5.84M$5.35M$3.90M$2.60M
Stock-based compensation$15.41M$28.21M$34.42M$33.67M$25.93M
Share buybacks—$0$13,000$20,000$35,000

Free plan shows the latest 5 periods; Pro shows all 6 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.